Back to search results
NCT06342284

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Recruiting
Not specifiedAges 18+Observational
The New York Proton Center
~40 participants
Updated 2026-04-13 on ClinicalTrials.gov
What's tested:Proton Beam Radiation with or without concurrent chemotherapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Demonstrate the feasibility of patient-generated health data collection during thoracic proton beam radiotherapy for lung cancer, based on the quantity of data collected from the day of radiotherapy initiation to the day of radiotherapy completion.
Measured over 4-5 Weeks

Conditions

Thoracic Cancer

Explore related trials

Lung Non-Small Cell CarcinomaLung Small Cell Carcinoma

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Nitin Ohri, MD · PRINCIPAL_INVESTIGATOR · Montefiore Medical Center

Who to contact

Nitin Ohri, MD
[email protected]
718-405-8550
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
Concurrent chemotherapy is permitted but not required..
Previous thoracic radiotherapy is allowed.
Ability to complete study surveys in English or Spanish
Age \>/= 18
Concurrent enrollment on other trials is permitted
Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
All patients must sign study-specific informed consent prior to study entry

Exclusion

Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

What this trial measures

  • Demonstrate the feasibility of patient-generated health data collection during thoracic proton beam radiotherapy for lung cancer, based on the quantity of data collected from the day of radiotherapy initiation to the day of radiotherapy completion.4-5 Weeks

    Feasibility assessed based on the quantity of data collected from day of radiotherapy initiation to day of radiotherapy completion. The feasibility of physical activity data collection will be assessed based on usage information provided by the Apple Watch. Descriptive statistics to be used to report the distribution of average use times in the study cohort and the proportion of days subjects wear the Apple Watch for at least 8 hours. The feasibility of daily home pulse oximeter data collection reported using frequencies and percentages. The feasibility of weekly electronic PRO collection reported using frequencies and percentages.